Masimo Corporation (MASI)

Medical monitoring technology company Masimo sued U.S. Customs and Border Protection on Wednesday over a decision by the agency that allowed Apple to import Apple Watches with blood-oxygen reading technology during a patent dispute between the companies.

MASI gains FDA clearance to expand O3 monitoring with delta hemoglobin parameters across all patient groups.

IRVINE, Calif.--(BUSINESS WIRE)-- #Masimo--Masimo O3®'s delta hemoglobin parameters have received FDA clearance for cerebral and somatic applications and all patient populations.

Masimo (MASI) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Masimo's second-quarter 2025 performance beats earnings and revenue estimates, expands margins and lifts 2025 outlook.

Masimo Corporation (NASDAQ:MASI ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Catherine M. Szyman - CEO & Director Eli Kammerman - Vice President of Business Development & Investor Relations Micah Young - Chief Financial Officer Conference Call Participants Frederick Allen Wise - Stifel, Nicolaus & Company, Incorporated, Research Division Jason M.

Masimo (MASI) came out with quarterly earnings of $1.33 per share, beating the Zacks Consensus Estimate of $1.23 per share. This compares to earnings of $0.86 per share a year ago.

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) today announced its financial results for the second quarter ended June 28, 2025. Second Quarter 2025 Results From Continuing Operations(1): GAAP revenue of $371 million, representing 8% growth on a reported basis; Non-GAAP revenue of $370 million, representing 7% growth on a constant currency basis(2); GAAP net income per diluted share of $0.82; and Non-GAAP net income per diluted share(2) of $1.33, which grew 46% versus prior.

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release second quarter 2025 financial results for the period ended June 28, 2025, after the market closes on Tuesday, August 5, 2025. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Katie Szyman, Chief Executive Officer, and Micah Young, Chief Financial Officer. To register for the conference call and receive the dial-in number, please use the link below. Upon registering, each.

IRVINE, Calif.--(BUSINESS WIRE)-- #Masimo--Masimo has joined the American Heart Association's Innovators' Network, a health care technology consortium.

SAN DIEGO, June 27, 2025 (GLOBE NEWSWIRE) -- Leading shareholder rights law firm Johnson Fistel, PLLP announces an investigation into potential breaches of fiduciary duties by current and former directors and officers of Masimo Corporation (NASDAQ: MASI). The investigation centers on whether Masimo's leadership failed to uphold their responsibilities to shareholders and may have violated corporate governance obligations.

SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by certain directors and officers of Masimo Corporation (NASDAQ: MASI) in relation to their obligations to the company's shareholders.

NEUCHATEL, Switzerland--(BUSINESS WIRE)-- #Masimo--A new study found that EEG-guided anesthesia using Masimo SedLine® improved anesthesia administration in children undergoing surgery.

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by certain directors and officers of Masimo Corporation (NASDAQ: MASI) in relation to their obligations to the company's shareholders. What can I do? If you are a current Masimo Corporation shareholder, you may have legal claims that may be brought on behalf of the company, against the company's directors and officers. If you wish to discuss this.

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies Global Healthcare Conference on Wednesday, June 4, 2025 at 1:25 p.m. Eastern time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of indus.

SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by certain directors and officers of Masimo Corporation (NASDAQ: MASI) in relation to their obligations to the company's shareholders.